Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
600867.SS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.23
-39%
0.11
vs 0.18
Q3.23
+27%
0.14
vs 0.11
Q4.23
+110%
0.21
vs 0.1
Q1.24
-15%
0.11
vs 0.13
Q2.24
N/A
-0.23
vs 0.11
Q3.24
-36%
0.09
vs 0.14
Q4.24
-94%
0.01
vs 0.21
Q1.25
-45%
0.06
vs 0.11
Q2.25
+117%
0.04
vs -0.23
Q3.25
-33%
0.06
vs 0.09
Sales Growth
YoY
Current
Estimates
Q2.23
+40%
701M vs 500M
Q3.23
+2%
725.2M vs 711.5M
Q4.23
+44%
980.3M vs 679.4M
Q1.24
-12%
587.7M vs 665.4M
Q2.24
-79%
146.8M vs 701M
Q3.24
-2%
707.7M vs 725.2M
Q4.24
-43%
556.9M vs 980.3M
Q1.25
+11%
651.5M vs 587.7M
Q2.25
+328%
628.8M vs 146.8M
Q3.25
-10%
640.1M vs 707.7M
Return on Equity
QoQ
Q2.23
+4%
0.04
vs 0.04
Q3.23
+4%
0.04
vs 0.04
Q4.23
+6%
0.06
vs 0.04
Q1.24
+3%
0.03
vs 0.06
Q2.24
-7%
-0.07
vs 0.03
Q3.24
+3%
0.03
vs -0.07
Q4.24
+0%
0
vs 0.03
Q1.25
+2%
0.02
vs 0
Institutionnal Ownership
Forecast
379%2026-Revenue
517%2026-EPS
1016%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Relative Strength
600867.SS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products for the treatment of diabetes and cardiovascular-based diseases in China. The company operates through Pharmaceutical Industry and Building Materials Industry segments. Its lead product portfolio includes insulin analogues, such as insulin glargine, Insulin aspart, and insulin lispro; antidiabetic drugs; and oral hypoglycemic drugs, as well as Gan Shulin pens, blood glucose meters, and other medical devices. It offers building materials. The company has a strategic alliance with Adocia. Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is based in Tonghua, China.
SHH
Unprofitable
Unprofitable
0.02Â ( 0.25%)
Relative Strenght
Volume Buzz
30%
Earning Acce
No
Dist 52w H.
18%Quote Panel
Key Metrics
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 600867.SS compares to sector?